-
公开(公告)号：WO2011100134A1
公开(公告)日：2011-08-18
申请号：PCT/US2011/023158
申请日：2011-01-31
Applicant: BAXTER INTERNATIONAL INC. , BAXTER HEALTHCARE S.A. , CHAN, William , CASTELLANOS, Ramiro , BHAGTANI, Reema A. , BERTOS, Georgios A. , LIN, Rongsheng , BOYER, Richard , DELCASTILLO, Jorge , SCHULTZ, Gary
Inventor： CHAN, William , CASTELLANOS, Ramiro , BHAGTANI, Reema A. , BERTOS, Georgios A. , LIN, Rongsheng , BOYER, Richard , DELCASTILLO, Jorge , SCHULTZ, Gary
CPC classification number: F16L55/04 , A61M5/14212 , A61M5/14224 , A61M5/14228 , A61M5/14232 , A61M5/16886 , A61M2205/3334 , A61M2206/22 , F04B11/0008 , F04B11/0016 , F04B11/0025 , F04B11/0091
Abstract: A medical fluid infusion system (10) including: a fluid pathway (16) for transporting a pulsatile flow of fluid; a dampening element (80) in communication with the fluid pathway, the dampening element configured to actively dampen pressure fluctuations of the pulsatile flow to smoothen the pulsatile fluid flow, the dampening element operable in any orientation; and a fluid flow sensor (50) disposed along the fluid pathway downstream of the dampening element to measure the flow rate of the smoothened fluid flow.
Abstract translation: 医疗流体输注系统（10）包括：流体路径（16），用于输送脉动流体的流体; 与所述流体通路连通的阻尼元件（80），所述阻尼元件构造成主动地抑制所述脉动流的压力波动以平滑所述脉动流体流，所述阻尼元件可在任何方向上操作; 和流体流量传感器（50），沿流体路径设置在阻尼元件的下游，以测量平滑流体流动的流速。
-
公开(公告)号：WO2009009226A4
公开(公告)日：2009-06-04
申请号：PCT/US2008064857
申请日：2008-05-27
Applicant: BAXTER INT , BAXTER HEALTHCARE SA , SLEPICKA JAMES S , PERRY MARK C , CHAN WILLIAM W , KIENMAN RICHARD E , LASSO ANGEL M , BUSBY DONALD D , ROGER RODOLFO G , HOGARD MICHAEL E
Inventor： SLEPICKA JAMES S , PERRY MARK C , CHAN WILLIAM W , KIENMAN RICHARD E , LASSO ANGEL M , BUSBY DONALD D , ROGER RODOLFO G , HOGARD MICHAEL E
CPC classification number: A61M1/28 , A61M1/1607 , A61M1/3656 , A61M5/16831 , A61M5/16854 , A61M2205/12 , A61M2205/13 , A61M2205/3368 , G01N27/10
Abstract: A dialysis system instrument includes a dialysis instrument (10), a disposable pumping and valving cassette apparatus (30) operable with pumping and valving actuators of the dialysis instrument, the disposable cassette (50) including an electronic cell (100c) and electronics associated with the electronic cell, the electronics configured to determine an electrical property of a solution flowing through the electronic cell of the disposable apparatus.
Abstract translation: 透析系统仪器包括透析仪器（10），可与透析仪器的泵送和阀门致动器一起操作的一次性泵送和阀门卡匣设备（30），一次性盒子（50）包括电子单元（100c） 所述电子单元被配置为确定流过所述一次性装置的所述电子单元的溶液的电特性。
-
公开(公告)号：WO2011100134A4
公开(公告)日：2011-10-27
申请号：PCT/US2011023158
申请日：2011-01-31
Applicant: BAXTER INT , BAXTER HEALTHCARE SA , CHAN WILLIAM , CASTELLANOS RAMIRO , BHAGTANI REEMA A , BERTOS GEORGIOS A , LIN RONGSHENG , BOYER RICHARD , DELCASTILLO JORGE , SCHULTZ GARY
Inventor： CHAN WILLIAM , CASTELLANOS RAMIRO , BHAGTANI REEMA A , BERTOS GEORGIOS A , LIN RONGSHENG , BOYER RICHARD , DELCASTILLO JORGE , SCHULTZ GARY
CPC classification number: F16L55/04 , A61M5/14212 , A61M5/14224 , A61M5/14228 , A61M5/14232 , A61M5/16886 , A61M2205/3334 , A61M2206/22 , F04B11/0008 , F04B11/0016 , F04B11/0025 , F04B11/0091
Abstract: A medical fluid infusion system (10) including: a fluid pathway (16) for transporting a pulsatile flow of fluid; a dampening element (80) in communication with the fluid pathway, the dampening element configured to actively dampen pressure fluctuations of the pulsatile flow to smoothen the pulsatile fluid flow, the dampening element operable in any orientation; and a fluid flow sensor (50) disposed along the fluid pathway downstream of the dampening element to measure the flow rate of the smoothened fluid flow.
Abstract translation: 一种药液输注系统（10），包括：流体通道（16），用于输送脉动流体流; 阻尼元件（80），其与所述流体通路连通，所述阻尼元件构造成主动地抑制所述脉动流的压力波动，以平滑所述脉动流体流，所述阻尼元件可以任何方向操作; 以及流体流动传感器（50），沿着润滑元件下游的流体路径设置，以测量平滑流体流的流速。
-
公开(公告)号：WO2009042261A4
公开(公告)日：2009-04-02
申请号：PCT/US2008/066101
申请日：2008-06-06
Applicant: BAXTER INTERNATIONAL INC. , BAXTER HEALTHCARE S.A. , MARTTILA, Alan, W. , CHAN, William, W. , BHAGTANI, Reema, Ashok
Inventor： MARTTILA, Alan, W. , CHAN, William, W. , BHAGTANI, Reema, Ashok
Abstract: A monitor for an extracorporeal therapy access site is disclosed. The monitor includes a bandage atop or adjacent the access site and a sensor for monitoring the bandage. The bandage includes a layer of polymer that expands when wetted with blood. The expansion causes a break in continuity of the sensor, or in an alternate embodiment, causes a sensor to cease detecting a target. When the break occurs, the control circuit monitoring the bandage sends a signal that a break has occurred, and a remote monitor then takes appropriate action, such as ceasing therapy, sending an alert, or sounding an alarm. In another embodiment, connecting wires in a continuity circuit are held apart by a polymer that dissolves when contacted by blood. If a leak occurs and a small portion of the polymer dissolves, the wires make contact, thus detecting a blood leak.
-
公开(公告)号：WO2009009222A2
公开(公告)日：2009-01-15
申请号：PCT/US2008/064086
申请日：2008-05-19
Applicant: BAXTER INTERNATIONAL INC. , BAXTER HEALTHCARE S.A. , KIENMAN, Richard, E. , ROUSCH, Daniel, E. , STECK, John, E. , SLEPICKA, James, S. , YARDIMCI, Atif, M. , HECHT, Gideon , LINDSAY, Jennifer, S. , BOBART, George, F. , BUSBY, Donald, D. , CHAN, William, W. , DING, Yuanpang, S. , TWINING, Amy , REITZ, Douglas, W. , KOPYCHEV, Andrey , OZER, Mehmet, B. , LAUMAN, Brian, C
Inventor： KIENMAN, Richard, E. , ROUSCH, Daniel, E. , STECK, John, E. , SLEPICKA, James, S. , YARDIMCI, Atif, M. , HECHT, Gideon , LINDSAY, Jennifer, S. , BOBART, George, F. , BUSBY, Donald, D. , CHAN, William, W. , DING, Yuanpang, S. , TWINING, Amy , REITZ, Douglas, W. , KOPYCHEV, Andrey , OZER, Mehmet, B. , LAUMAN, Brian, C
IPC: A61M1/16
CPC classification number: A61M5/44 , A61M1/1635 , A61M1/1696 , A61M1/342 , A61M1/3434 , A61M1/3437 , A61M1/3458 , A61M2205/127
Abstract: A dialysis fluid heating system includes a plurality of conductive tubes; first and second end caps located at first and second ends of the tubes, respectively, the first end cap including a dialysis fluid inlet and a dialysis fluid outlet, the end caps and the tubes configured such that dialysis fluid can flow from the fluid inlet of the first end cap, through at least one first tube to the second end cap, and through at least one second tube back to the first end cap; a conductive wire wound around an outside of the conductive tubes; and electronics configured to supply power to the conductive wire, the wire forming a primary coil of a transformer, the tubes forming a secondary coil of the transformer.
Abstract translation: 透析液加热系统包括多个导电管; 分别位于所述管的第一端和第二端的第一和第二端盖，所述第一端盖包括透析液入口和透析液出口，所述端盖和所述管构造成使得透析液可以从所述管的第一端和第二端的流体入口 第一端盖，通过至少一个第一管到达第二端盖，并且通过至少一个第二管返回到第一端盖; 缠绕在导电管外侧的导线; 以及配置为向导线供电的电子装置，所述导线形成变压器的初级线圈，所述管形成变压器的次级线圈。
-
Patent Agency Ranking6.发明申请DEVICE, SYSTEM AND METHOD FOR REDUCING AN INTERACTION TIME FOR A CONTACTLESS TRANSACTION 审中-公开用于减少无接触事务的交互时间的装置，系统和方法
公开(公告)号：WO2007038743A2
公开(公告)日：2007-04-05
申请号：PCT/US2006038047
申请日：2006-09-28
Applicant: VISA INT SERVICE ASS , HILL TRUDY , SAHOTA JAGDEEP SINGH , AABYE CHRISTIAN , WAGNER KIM , OCHIEANO ANITA , OPPENLANDER CAROLE , CHAN WILLIAM CHI YUEN , GLENDENNING CRAIG ALLEN
Inventor： HILL TRUDY , SAHOTA JAGDEEP SINGH , AABYE CHRISTIAN , WAGNER KIM , OCHIEANO ANITA , OPPENLANDER CAROLE , CHAN WILLIAM CHI YUEN , GLENDENNING CRAIG ALLEN
CPC classification number: G06Q20/352 , G06K7/0008 , G06Q20/04 , G06Q20/3674 , G06Q20/382 , G06Q20/38215 , G06Q20/3825 , G06Q20/40 , G06Q20/401 , G06Q20/4016 , G06Q20/409 , G06Q30/06 , G07F7/0826 , G07F7/088 , G07F7/1008 , G07F7/1016
Abstract: A method. The method comprises, at a reader, performing at least one transaction-based risk management process prior to energizing a contactless interface, initiating communication with a card utilized for the contactless transaction, receiving information associated with the card, and terminating communication with the card prior to authorizing the contactless transaction.
Abstract translation: 一个方法。 该方法包括，在读取器处，在激励非接触式接口之前执行至少一个基于交易的风险管理过程，发起与用于非接触式交易的卡的通信，接收与卡相关联的信息，以及终止与卡之前的通信 授权非接触式交易。
-
公开(公告)号：WO2007038581A1
公开(公告)日：2007-04-05
申请号：PCT/US2006/037650
申请日：2006-09-27
Applicant: BASF AKTIENGESELLSCHAFT , VIRANI, Naheed , SEAGRAVES, Thomas , MUSSELMAN, Wayne, David , CHAN, William, Stewart , KNAEBEL, Kent, S. , SHIN, Heungsoo
Inventor： VIRANI, Naheed , SEAGRAVES, Thomas , MUSSELMAN, Wayne, David , CHAN, William, Stewart , KNAEBEL, Kent, S. , SHIN, Heungsoo
CPC classification number: C01B21/1418 , B01D53/047 , B01D2257/402 , Y02C20/10 , Y02P20/153
Abstract: Hydroxylamine is formed in a reactor through a partial hydrogenation of nitric oxide gas (NO) with hydrogen gas (H 2 ) in an aqueous medium with nitrogen gas (N 2 ) as an inert gas. The formation of the hydroxylamine forms nitrous oxide gas (N 2 O). The gases and the water vapor are flowed away from the reactor in a vent gas stream enabling recycling of the gases. The N 2 O is removed from the vent gas stream to reduce flammability. Once the N 2 O is removed, the NO, H 2 , and N 2 are recycled and re-used in the reactor to form additional hydroxylamine. The N 2 O removed from the vent gas stream can be commercially sold or economically discarded.
Abstract translation: 羟胺在反应器中通过在氮气（N 2/2）的水性介质中将一氧化氮气体（NO）与氢气（H 2 H 2）部分氢化形成为反应器， 惰性气体。 羟胺的形成形成一氧化二氮气体（N 2 O 2）。 气体和水蒸气以能够再循环气体的排气气流从反应器中流出。 从排出气流中除去N 2 O 2以降低可燃性。 一旦去除了N 2 O 2，则NO，H 2 N 2和N 2 O 2被再循环并重新用于反应器以形成额外的 羟胺。 从排放气流中除去的N 2 O 2可以商业销售或经济地丢弃。
-
8.发明申请CONJUGATION OF PHARMACEUTICALLY ACTIVE AGENTS WITH TRANSTHYRETIN LIGANDS THROUGH ADJUSTABLE LINKERS TO INCREASE SERUM HALF-LIFE 审中-公开通过可调节的连接物与具有血清生长素的TRANSTHYRETIN配体结合的药物活性剂
公开(公告)号：WO2016025129A1
公开(公告)日：2016-02-18
申请号：PCT/US2015/041189
申请日：2015-07-20
Applicant: ALHAMADSHEH, Mamoun, M. , PARK, Miki, S. , CHAN, William, K. , LI, Xiaoling , PENCHALA, Sravan, C. , MILLER, Mark, R.
Inventor： ALHAMADSHEH, Mamoun, M. , PARK, Miki, S. , CHAN, William, K. , LI, Xiaoling , PENCHALA, Sravan, C. , MILLER, Mark, R.
IPC: A01N43/38
CPC classification number: A61K47/64 , A61K31/00 , A61K31/4745 , A61K38/00 , A61K47/545 , A61K49/0052 , C07D231/12
Abstract: A delivery system for active agents, and methods of making and using the systems, are provided. The delivery systems have (i) a ligand that is selective for an endogeneous plasma protein in the serum of a subject; and, (ii) a linker configured for operatively attaching the ligand covalently to an active agent to increase the half-life of the active agent in the serum.
Abstract translation: 提供了用于活性剂的递送系统以及制备和使用该系统的方法。 递送系统具有（i）对受试者血清中的内质血浆蛋白是选择性的配体; 和（ii）被配置用于将配体共价地连接到活性剂上以增加血清中活性剂的半衰期的连接体。
-
公开(公告)号：WO2011005766A2
公开(公告)日：2011-01-13
申请号：PCT/US2010/041073
申请日：2010-07-06
Inventor： CHAN, William Chi Yuen , NG, Kong Boon
IPC: G06Q20/00
CPC classification number: G06Q20/327 , G06Q20/20 , G06Q20/22 , G06Q20/3278 , G06Q20/352 , G06Q20/40 , G06Q20/4016 , G06Q50/30 , G07B15/00
Abstract: A system, apparatus, and method for enabling effective use of a contactless payment device in a transit system. The invention may be implemented in a manner that separates the authentication process from the pre-authorization process, thereby permitting a transit system patron to access and begin use of the transit system prior to authorization of the transaction by the issuer of the device.
Abstract translation: 用于在运输系统中有效使用非接触式支付设备的系统，设备和方法。 本发明可以以认证过程与预授权过程分离的方式实现，从而允许交通系统顾客在设备的发行者授权交易之前访问并开始使用交通系统。 p>
-
10.发明申请
公开(公告)号：WO2009009227A4
公开(公告)日：2009-05-14
申请号：PCT/US2008064865
申请日：2008-05-27
Applicant: BAXTER INT , BAXTER HEALTHCARE SA , SLEPICKA JAMES S , PERRY MARK C , CHAN WILLIAM W , KIENMAN RICHARD E , LASSO ANGEL M , BUSBY DONALD D , ROGER RODOLFO G , HOGARD MICHAEL E
Inventor： SLEPICKA JAMES S , PERRY MARK C , CHAN WILLIAM W , KIENMAN RICHARD E , LASSO ANGEL M , BUSBY DONALD D , ROGER RODOLFO G , HOGARD MICHAEL E
CPC classification number: A61M1/28 , A61M1/1607 , A61M1/3656 , A61M2205/12 , G01N27/08
Abstract: A dialysate testing method in one embodiment includes placing electrical contacts in a dialysate flow path, measuring an electrical property of the dialysate as it flows through the flow path and past the contacts, and determining whether the dialysate has been mixed properly from the detected electrical property. A dialysate testing method in another embodiment includes flowing dialysate past a pair of electrical contacts, calculating a conductivity of the dialysate using an algorithm that takes into account a geometry of the contacts, and using the calculated conductivity to determine if the dialysate has been removed properly.
Abstract translation: 在一个实施方案中，透析液测试方法包括将电触点放置在透析液流动路径中，当透析液流过流路并经过触点时，测量透析液的电性质，以及确定透析液是否已经从检测到的电性能 。 在另一个实施方案中的透析液测试方法包括使透析液流过一对电接触，使用考虑到接触的几何形状的算法计算透析液的电导率，并使用计算出的电导率来确定透析液是否已经被正确除去 。
-
-
-
-
-
-
-
-
-
Search Results
23
records
(took 0.019 seconds)
